News
BIOL
--
0.00%
--
Biolase Granted European Patent Titled 'HANDPIECE FINGER SWITCH FOR ACTUATION OF HANDHELD MEDICAL INSTRUMENTATION'
https://data.epo.org/publication-server/pdf-document?pn=2521506&ki=B1&cc=EP
Benzinga · 2d ago
BIOLASE Hosts Nearly 400 Dental Professionals During Webinar On Landmark Study On Lasers And Managing Periodontitis
BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced that it hosted nearly 400 dental professionals last Thursday evening during a panel discussion on the NEW Journal of Periodontology landmark study from the McGuire Institute comparing periodontal flap surgery to BIOLASE
PR Newswire · 09/15 13:30
BIOLASE To Present At H.C. Wainwright's 22nd Annual Global Investor Conference
BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, announced today that Todd Norbe, President and Chief Executive Officer and John Beaver, Chief Operating Officer and Chief Financial Officer, will be providing an overview of the Company, as well as recent progress and achievements at the
PR Newswire · 09/11 21:05
BIOLASE to Highlight Progress and Recent Achievements at the Colliers & Co. Institutional Investor Conference
BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, announced today that Todd Norbe, President and Chief Executive Officer and John Beaver, Chief Operating Officer and Chief Financial Officer, will be providing an overview of the Company, as well as recent progress and achievements at the
PR Newswire · 09/03 12:30
BIOLASE Regains Nasdaq Compliance For Minimum Stockholder Equity
PR Newswire · 08/18 11:30
BIOLASE Regains Nasdaq Compliance For Minimum Stockholder Equity
FOOTHILL RANCH, Calif., Aug. 18, 2020 /PRNewswire/ -- BIOLASE, Inc.(NASDAQ:BIOL), the global leader in dental lasers, announced today that it received notification from the Listing Qualifications
Benzinga · 08/18 10:39
Biolase Q2 EPS $(0.08) Beats $(0.17) Estimate, Sales $2.90M Beat $2.09M Estimate
Biolase (NASDAQ:BIOL) reported quarterly losses of $(0.08) per share which beat the analyst consensus estimate of $(0.17) by 52.94 percent. This is a 38.46 percent increase over losses of $(0.13) per share from the same
Benzinga · 08/13 20:14
Biolase EPS beats by $0.05, beats on revenue
Biolase (BIOL): Q2 GAAP EPS of -$0.12 beats by $0.05.Revenue of $2.94M (-66.0% Y/Y) beats by $0.85M.Shares +1%.Press Release
Seekingalpha · 08/13 20:07
Biolase EPS beats by $0.05, beats on revenue
Biolase (BIOL): Q2 GAAP EPS of -$0.12 beats by $0.05.Revenue of $2.94M (-66.0% Y/Y) beats by $0.85M.Shares +1%.Press Release
Seekingalpha · 08/13 20:07
BIOLASE Filing Shows Registration For 18.62M Share Common Stock Offering
Benzinga · 07/24 10:03
BIOLASE Announces Closing Of Oversubscribed Rights Offering
BIOLASE, Inc. (NASDAQ: BIOL), a global leader in dental lasers, further strengthened its balance sheet today as it closed the Company's previously announced rights offering (the "Offering"). At the closing, BIOLASE issued and sold an aggregate of 18,000 shares
PR Newswire · 07/22 20:05
BIOLASE's oversubscribed rights offering expires
BIOLASE (BIOL -5.9%) announced expiration of its oversubscribed (229%) rights offering on July 15, 2020; subscriptions totaled 49,375 units. Units at a sub
seekingalpha · 07/16 21:11
BIOLASE Announces Expiration Of Oversubscribed Rights Offering
BIOLASE, Inc. (NASDAQ: BIOL), a global leader in dental lasers, announced today the expiration of the Company's rights offering, which was oversubscribed. The subscription period for its previously announced rights offering (the "Offering") of units at a subsc
PR Newswire · 07/16 10:30
BIOLASE to Present at COVID-19 Webinar Hosted by Maxim Group on July 16, 2020
BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, announced today that BIOLASE CEO Todd Norbe has been invited to participate in a panel discussion on Re-Engaging Medical Practices in an Era of COVID-19, presented by Maxim Group and M-Vest on T
PR Newswire · 07/09 10:30
BIOLASE's Epic Hygiene Laser Meets Guidelines to Minimize Risk of COVID-19 Transmission
PR Newswire · 07/08 14:00
BIOLASE, Inc. Announces Commencement of Rights Offering Subscription Period
PR Newswire · 07/02 11:30
BIOLASE Reports Commencement Of Rights Offering Subscription Period
BIOLASE, Inc. (NASDAQ:BIOL), a global leader in dental lasers, today announced that the subscription period for the rights offering has commenced. If exercising subscription rights through a broker, dealer, bank or other
Benzinga · 07/02 10:30
BIOLASE Announces a Shareholder Rights Program
Under the proposed rights offering, BIOLASE will distribute one non-transferable subscription right for each share of common stock and each June 2020 Warrant (on an as-if-converted-to-common-stock basis) held on the
Benzinga · 06/22 10:33
BIOLASE, Inc. Informs Stockholders of Key Dates and Terms Related to Announced Rights Offering
BIOLASE, Inc. (NASDAQ: BIOL), a global leader in dental lasers, today provided an informational update to stockholders regarding its proposed rights offering and the expected key dates and terms relative to the offering. Stockholders of record on Wednesday Jul
PR Newswire · 06/22 10:30
Biolase files for subscription rights offering
Seeking Alpha - Article · 06/19 20:29
Webull provides a variety of real-time BIOL stock news. You can receive the latest news about BIOLASE through multiple platforms. This information may help you make smarter investment decisions.
About BIOL
BIOLASE, Inc. (BIOLASE) is a medical device company that develops, manufactures, markets and sells laser systems in dentistry and medicine. The Company markets, sells, and distributes dental imaging equipment, including cone beam digital x-rays and computer-aided design (CAD)/computer-aided manufacturing (CAM) intra-oral scanners, in-office, chair-side milling machines and three-dimensional (3-D) printers. It offers two categories of laser system products: WaterLase (all-tissue) systems and Diode (soft tissue) systems. Its brand, WaterLase, uses a combination of water and laser energy to perform procedures performed using drills, scalpels, and other traditional dental instruments for cutting soft and hard tissue. It also offers its Diode laser systems to perform soft tissue, pain therapy, and cosmetic procedures, including teeth whitening. Its Waterlase and Diode systems use disposable laser tips of differing sizes and shapes depending on the procedures being performed.
More